Benitec Biopharma Inc. - Enterprise Value

The Enterprise Value as of June 2026 (TTM) for Benitec Biopharma Inc. (BNTC) is 135.02M

According to Benitec Biopharma Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 135.02M. This represents a change of -66.02% compared to the average of 397.28M of the last 4 quarters.

Benitec Biopharma Inc. (BNTC) Historical Enterprise Value (quarterly & annually)

How has BNTC Enterprise Value performed in the past?

The mean historical Enterprise Value of Benitec Biopharma Inc. over the last ten years is 63.42M. The current 135.02M Enterprise Value has changed 21.19% with respect to the historical average. Over the past ten years (40 quarters), BNTC's Enterprise Value was at its highest in in the September 2025 quarter at 488.88M. The Enterprise Value was at its lowest in in the March 2023 quarter at -51954.93.

Benitec Biopharma Inc. (BNTC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Benitec Biopharma Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Benitec Biopharma Inc. (BNTC) Average Enterprise Value

How has BNTC Enterprise Value performed in the past?

The current Enterprise Value of Benitec Biopharma Inc. (BNTC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Benitec Biopharma Inc. (BNTC) Enterprise Value vs. Peers

How is BNTC’s Enterprise Value compared to its peers?

Benitec Biopharma Inc.’s Enterprise Value is less than Solid Biosciences Inc. (371.92M), less than Neurogene Inc. (383.20M), less than Autolus Therapeutics plc (350.91M), less than Quantum-Si incorporated (165.14M), less than PureTech Health plc (186.91M), less than Lineage Cell Therapeutics, Inc. (268.11M), less than XOMA Royalty Corp. (555.61M), less than I-Mab (1.14B), less than Galectin Therapeutics Inc. (307.65M), less than Ocugen, Inc. (421.21M),

Build a custom stock screener for Benitec Biopharma Inc. (BNTC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Benitec Biopharma Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Benitec Biopharma Inc. (BNTC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Benitec Biopharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.